HLA-A and infection: Newer murine models with human tapasin and proteasome might improve vaccine potency and be more relevant to human vaccine development.39 Alternatively, our optimized cleavage sites, based on human infection, using human PBMC, may work as effectively in our HLA-A*1101 mice.